Clinical Trial Update: Tofacitinib Ointment For Chronic Plaque Psoriasis [Phase 2]

View source ↗

Summary

Pfizer-conducted Phase 2 trial evaluating topical tofacitinib ointment for chronic plaque psoriasis has completed, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Tofacitinib (tofacitinib)

Snippet

Sponsor: Pfizer | Conditions: Psoriasis Vulgaris, Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2015-11-25